| Application no. and date | 09791127.5 (espacenet) (Federated) (European Patent Register), 20090804 | | Patent/reg. no. and date | DK/EP 2326329, 20170111 | | Publication date | 20110601 | | Priority no. and date | US 85913 P, 20080804, US 172466 P, 20090424 | | EP pub. no. and date |
EP 2326329 20110601 | | Effective date | | | Applicant/owner | Wyeth LLC, 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | 60803DK01 | | Inventor | ZACHARCHUK, Charles, 5 Abby Road
Westford
MA 01886, US,
WANG, Kenneth, 165 Ash Street
Unit 1
Waltham
MA 02453, US,
BINLICH, Florence, 35 Avenue Thierry
F-92410 Ville D'avray, FR,
QUINN, Susan, 133 Gay Street
Norwood
MA 02062, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/7068 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Antineoplastiske kombinationer af 4-anilino-3-cyanoquinoliner og capecitabin | | Int. application no. | US2009052644 | | Int. publication no. | WO2010017163 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
